Here, we used the highly metastatic MDA-MB-231 LM2-4 orthotopic model of TNBC, a prototypic model for studying human breast cancer metastasis in vivo [10,11], to investigate the effect of pharmacologically targeting CAIX activity and angiogenesis, alone and in combination, on tumor growth and metastasis. Here, CA9 is linked to breast carcinoma.